Patient‐Reported Outcomes From a Randomized Controlled Trial Comparing Right Unilateral Electroconvulsive Therapy With Algorithm‐Based Pharmacological Treatment in Bipolar Depression, With Long‐Term Follow‐Up on Pharmacological Treatment
Authors:
- 14 March 2026
- journal article
- research article
- Published by Wiley in Bipolar Disorders
- Vol. 28 (3) , e70105
Abstract
Objective: The objective was to compare acute and long‐term patient‐reported outcome measures (PROMs) of symptoms and functioning in treatment‐resistant bipolar depression following right unilateral (RUL) electroconvulsive therapy (ECT) and algorithm‐based pharmacological treatment (APT). Methods: Inpatients with treatment‐resistant bipolar depression were randomized to 6 weeks of RUL ECT or APT, followed by pharmacological maintenance treatment for 6 months. Three PROMS—the Medical Outcome Short‐Form Health Assessment (RAND‐36), the Everyday Memory Questionnaire (EMQ‐28), and the Patient Global Impression of Improvement (PGI‐I)—and the clinician‐rated Montgomery and Åsberg Depression Rating Scale (MADRS) were applied pretreatment, posttreatment, and 6 months posttreatment. Group comparisons were performed using linear mixed‐effects analysis. Results: Seventy‐three patients (N RUL ECT = 38, N APT = 35) were randomized to treatment, of which 44 (N RUL ECT = 23, N APT = 21) completed acute treatment, and 39 (N RUL ECT = 20, N APT = 19) completed the 6‐month follow‐up. Immediately posttreatment, RUL ECT and APT patients showed improvements in seven and three of the eight RAND‐36 dimensions, respectively, while improvements on the PGI‐I were greater for RUL ECT than for APT patients (2.2 vs. 2.9, p = 0.010) as were those on the MADRS (13.1 vs. 18.1, p = 0.010), with no group difference on the EMQ‐28. At 6 months, there were no significant group differences for any measure. EMQ‐28 scores improved significantly from pretreatment to the 6‐month follow‐up only in the RUL ECT group (122.5 vs. 91.6, p < 0.001). Conclusion: Two PROMs and the clinician‐rated MADRS favored RUL ECT over APT after 6 weeks of treatment. These findings show the acute benefit of RUL ECT in the treatment of bipolar depression.Keywords
This publication has 29 references indexed in Scilit:
- The utility of patient‐reported outcome measures in mental healthWorld Psychiatry, 2022
- The concept and management of acute episodes of treatment-resistant bipolar disorder: a systematic review and exploratory meta-analysis of randomized controlled trialsJournal of Affective Disorders, 2020
- Concordance between clinician-rated and patient reported outcome measures of depressive symptoms in treatment resistant depressionJournal of Affective Disorders, 2020
- Neurognitive function and symptom remission 2 years after ECT in major depressive disordersJournal of Affective Disorders, 2019
- Patient centric measures for a patient centric era: Agreement and convergent between ratings on The Patient Global Impression of Improvement (PGI-I) scale and the Clinical Global Impressions – Improvement (CGI-S) scale in bipolar and major depressive disorderEuropean Psychiatry, 2018
- Effects of a right unilateral ultrabrief pulse electroconvulsive therapy course on health related quality of life in elderly depressed patientsJournal of Affective Disorders, 2017
- Significantly improved neurocognitive function in major depressive disorders 6 weeks after ECTJournal of Affective Disorders, 2016
- Objective Cognitive Performance Associated with Electroconvulsive Therapy for Depression: A Systematic Review and Meta-AnalysisBiological Psychiatry, 2010
- A systematic review of long-term studies of drug treated and non-drug treated depressionJournal of Affective Disorders, 2009
- Continuation Electroconvulsive Therapy vs Pharmacotherapy for Relapse Prevention in Major DepressionArchives of General Psychiatry, 2006